Why the study?
NOACs are approved as safer alternatives to warfarin, prompting a review of their risks and benefits with a focus on gastrointestinal bleeding and underlying molecular and pathophysiological mechanisms.
Do NOACs compared to warfarin alter the risk and severity of gastrointestinal bleeding in patients requiring anticoagulation?
Do NOACs compared to warfarin alter the risk and severity of gastrointestinal bleeding in patients requiring anticoagulation?
NOACs offer a safer profile with less severe gastrointestinal bleeding compared to warfarin, though careful selection is needed for patients at high risk of GI bleeding.
Answers are grounded in this paper and cite their sources.
Supports preferring apixaban to minimize GI bleeding in high-risk patients; leaves open need for prospective mechanistic confirmation.
Novel oral anticoagulants (NOACs) are drugs approved for the prevention and treatment of many thromboembolic cardiovascular conditions as a safer alternative to warfarin. We reviewed studies published in PubMed®, UpToDate®, Web of Science®, and Cochrane® about NOACs’ risks and benefits in patients requiring anticoagulation, with a focus on gastrointestinal bleeding and on molecular and pathophysiological mechanisms underlying the risk of bleeding in patients treated with them. Apixaban resulted in a lower rate of gastrointestinal bleeding compared to dabigatran and rivaroxaban. However, data reported that gastrointestinal bleeding in patients treated with NOACs was less severe compared to warfarin. Studies show promising results on the increased and widespread use of NOACs in patients who require anticoagulation (for example—in case of atrial fibrillation or high risk of venous thromboembolism), reporting an overall lower risk of major bleeding events. The profile of NOACs was more effective and secure compared to warfarin, but a more careful medical prescription is required in patients who are at high risk of gastrointestinal bleeding.
No takes yet. Share an insight, caveat, or question.
Saviano et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: